Trials / Conditions / Esophageal Squamous Cell Carcinomas
Esophageal Squamous Cell Carcinomas
5 registered clinical trials studyying Esophageal Squamous Cell Carcinomas.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Canc NCT05621707 | Shanghai Chest Hospital | Phase 2 |
| Active Not Recruiting | SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma. NCT05022654 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 2 |
| Unknown | Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial NCT05103501 | Shanghai Chest Hospital | Phase 2 |
| Unknown | Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Sur NCT04741490 | Fuzhou General Hospital | N/A |
| Unknown | Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Car NCT02611700 | Biotech Pharmaceutical Co., Ltd. | Phase 3 |